GLP-1 therapy associated with more dizziness and fainting

https://www.news-medical.net/news/20260614/GLP-1-therapy-associated-with-more-dizziness-and-fainting.aspx Northwestern Medicine scientists have identified a safety concern associated with GLP-1 drugs. Using health record data, the research team tracked more than 42,000 adults already taking at least two types of blood pressure medications. After starting GLP-1s, these patients experienced higher rates of dizziness, fainting and other events related to low blood pressure, also known as hypotension.